Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study

Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study

BackgroundProton pump inhibitors (PPIs) are the most effective antacids and are widely used in the treatment of acid-related diseases. However, the impact of PPIs on bone remains controversial. This study aimed to explore the association between PPIs and osteoporosis-related adverse events in the re...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingkai Di, Nan Yang, Yicong Zhao, Shuai Chen, Zijian Guo, Dongdong He, Chuan Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
proton pump inhibitors
osteoporosis
FAERS
adverse drug events
drug safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1582908/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1582908/full

Similar Items